<DOC>
	<DOCNO>NCT00033072</DOCNO>
	<brief_summary>The purpose study assess potential interaction intravenous methamphetamine oral selegiline .</brief_summary>
	<brief_title>Assessment Potential Interactions Between Methamphetamine Selegiline - 1</brief_title>
	<detailed_description>To determine safety selegiline concurrent d-methamphetamine challenge 15mg &amp; 30mg i.v . focus cardiovascular response ( HR , BP ) i.v . methamphetamine challenge . This randomized , single-blind , placebo-controlled , two-arm study design evaluate safety selegiline treatment , compare placebo treatment , concurrent i.v . methamphetamine challenge .</detailed_description>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Volunteers meet DSM4 criterion methamphetamine abuse dependence ; nontreatment seek individual Be able verbalize understanding consent form ; provide write informed consent Please contact site information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2003</verification_date>
</DOC>